Clinical Trial Detail

NCT ID NCT02108652
Title A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

ureter transitional cell carcinoma

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Atezolizumab

Age Groups: adult

No variant requirements are available.